Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Versartis Inc (NASDAQ:VSAR)

2.65
Delayed Data
As of Oct 20
 -0.10 / -3.64%
Today’s Change
2.35
Today|||52-Week Range
24.00
-82.21%
Year-to-Date
No recent news for Versartis Inc.

Today’s Trading

Previous close2.75
Today’s open2.75
Day’s range2.65 - 2.75
Volume932,405
Average volume (3 months)1,414,949
Market cap$94.4M
Dividend yield--
Data as of 10/20/2017

Growth & Valuation

Earnings growth (last year)-9.51%
Earnings growth (this year)-27.91%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book0.61

Competitors

 Today’s
change
Today’s
% change
HSKAHeska Corp+0.16+0.17%
PRTKParatek Pharmaceutic...-0.05-0.22%
AMPHAmphastar Pharmaceut...+0.05+0.27%
RETAReata Pharmaceutical...+1.01+3.18%
Data as of 10/20/2017

Financials

Next reporting dateNovember 9, 2017
EPS forecast (this quarter)-$1.01
Annual revenue (last year)$0.00
Annual profit (last year)-$95.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Jay P. Shepard
Chief Operating &
Financial Officer
Joshua T. Brumm
Corporate headquarters
Menlo Park, California

Forecasts